Screening of specific aptamers against chlorpromazine and construction of novel ratiometric fluorescent aptasensor based on metal-organic framework

M Song, C Li, S Wu, N Duan - Talanta, 2023 - Elsevier
Chlorpromazine is a phenothiazine representative drug that can be used to anesthetize and
calm animals. However, chlorpromazine excess may lead to residual persistence in edible …

Cell surface Nucleolin represents a novel cellular target for neuroblastoma therapy

C Brignole, V Bensa, NA Fonseca, G Del Zotto… - Journal of Experimental …, 2021 - Springer
Background Neuroblastoma (NB) represents the most frequent and aggressive form of
extracranial solid tumor of infants. Nucleolin (NCL) is a protein overexpressed and partially …

Targeted protein degradation: clinical advances in the field of oncology

AKAA Salama, MV Trkulja, E Casanova… - International Journal of …, 2022 - mdpi.com
The field of targeted protein degradation (TPD) is a rapidly developing therapeutic modality
with the promise to tame disease-relevant proteins in ways that are difficult or impossible to …

Targeting drug delivery and efficient lysosomal escape for chemo-photodynamic cancer therapy by a peptide/DNA nanocomplex

Q Wang, Z He, H Zhu, W Gao, N Zhang, J Li… - Journal of Materials …, 2022 - pubs.rsc.org
A peptide/DNA nanocomplex was developed for the targeted delivery of chemotherapeutics
and photosensitizers to cancer cells for efficient combination therapy. The chemotherapeutic …

Nanomedicine for renal cell carcinoma: imaging, treatment and beyond

R Wu, K Wang, Y Gai, M Li, J Wang, C Wang… - Journal of …, 2023 - Springer
The kidney is a vital organ responsible for maintaining homeostasis in the human body.
However, renal cell carcinoma (RCC) is a common malignancy of the urinary system and …

[HTML][HTML] Non-small molecule PROTACs (NSM-PROTACs): protein degradation kaleidoscope

S Ma, J Ji, Y Tong, Y Zhu, J Dou, X Zhang, S Xu… - … Pharmaceutica Sinica B, 2022 - Elsevier
The proteolysis targeting chimeras (PROTACs) technology has been rapidly developed
since its birth in 2001, attracting rapidly growing attention of scientific institutes and …

Recent advances in aptamer applications for analytical biochemistry

G Zon - Analytical biochemistry, 2022 - Elsevier
Aptamers are typically defined as relatively short (20–60 nucleotides) single-stranded DNA
or RNA molecules that bind with high affinity and specificity to various types of targets …

Aptamer‐conjugated mesoporous polydopamine for docetaxel targeted delivery and synergistic photothermal therapy of prostate cancer

L Dai, D Wei, J Zhang, T Shen, Y Zhao, J Liang… - Cell …, 2021 - Wiley Online Library
Objectives It is imperative to develop efficient strategies on the treatment of prostate cancer.
Here, we constructed multifunctional nanoparticles, namely AS1411@ MPDA‐DTX (AMD) …

Dual-aptamer-engineered M1 macrophage with enhanced specific targeting and checkpoint blocking for solid-tumor immunotherapy

H Qian, Y Fu, M Guo, Y Chen, D Zhang, Y Wei, F Jin… - Molecular Therapy, 2022 - cell.com
Chimeric antigen receptor T (CAR-T) cell therapy has faced a series of challenges and has
shown very little efficacy in solid tumors to date. Although genetically engineered …

Aptamers: Cutting edge of cancer therapies

S Shigdar, B Schrand, PH Giangrande… - Molecular Therapy, 2021 - cell.com
The development of an aptamer-based therapeutic has rapidly progressed following the first
two reports in the 1990s, underscoring the advantages of aptamer drugs associated with …